; and (ii) the availability of such opportunity is a result of SARS–CoV–2 or COVID–19; or (B) that a product, service, benefit, or other opportunity relating to testing or treatment for or vaccination against SARS–CoV–2 or COVID–19, or relating to payment for such testing, treatment, or vaccination, is or may be available to such person, the household of such person, or a member of such household, when such opportunity is not in fact so available.